Merit Net Income from 2010 to 2026
| MMSI Stock | USD 79.63 0.26 0.33% |
Net Income | First Reported 1989-03-31 | Previous Quarter 32.6 M | Current Value 27.8 M | Quarterly Volatility 8.3 M |
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 138.5 M, Interest Expense of 37.7 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 2.71, Dividend Yield of 0.0 or PTB Ratio of 3.62. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
Merit | Net Income | Build AI portfolio with Merit Stock |
The Net Income trend for Merit Medical Systems offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Merit Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Merit Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Merit Medical Systems over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Merit Medical Systems financial statement analysis. It represents the amount of money remaining after all of Merit Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Merit Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 120.36 M | 10 Years Trend |
|
Net Income |
| Timeline |
Merit Net Income Regression Statistics
| Arithmetic Mean | 47,791,096 | |
| Geometric Mean | 26,623,299 | |
| Coefficient Of Variation | 102.10 | |
| Mean Deviation | 39,380,359 | |
| Median | 23,802,000 | |
| Standard Deviation | 48,793,847 | |
| Sample Variance | 2380.8T | |
| Range | 155.2M | |
| R-Value | 0.80 | |
| Mean Square Error | 903.1T | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | 7,756,435 | |
| Total Sum of Squares | 38093.4T |
Merit Net Income History
Other Fundumenentals of Merit Medical Systems
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Merit Medical Net Income component correlations
About Merit Medical Financial Statements
Investors use fundamental indicators, such as Merit Medical's Net Income, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Income | 138.4 M | 145.3 M | |
| Net Income Applicable To Common Shares | 85.7 M | 90 M | |
| Net Income From Continuing Ops | 138.4 M | 145.3 M | |
| Net Income Per Share | 1.86 | 1.95 | |
| Net Income Per E B T | 0.72 | 0.62 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Merit Medical Correlation against competitors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Earnings Share 1.92 | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets |
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.